Virtual Ward for Home Dialysis

NCT01912001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2016-05-12

No results posted yet for this study

Summary

Home based renal replacement therapy (RRT), including peritoneal dialysis (PD) and home hemodialysis(HHD), offers enhanced quality of life and clinical advantages compared to conventional in-center hemodialysis. Patients with end stage renal disease, that is failure of the kidneys such that dialysis is required, are at high risk for adverse health events especially during a period of transition following a change in care settings. The investigators aim to implement a Home Dialysis Virtual Ward (HDVW) strategy of telephone follow-up, which is targeted to minimize gaps of care during transitions in care.

The investigators aim to have clinicians follow patients by telephone if they meet one of the following four criteria;

1. Discharge from hospital.
2. Having an interventional procedure.
3. Prescription of an antibiotic.
4. Completion of Home Dialysis training.

The major goal of this HDVW initiative is to provide appropriate and effective supports to medically complex patients in a targeted window of vulnerability.

Conditions

Interventions

OTHER

Telephone follow-up

OTHER

Sympton Assessment

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY
  • Vancouver General Hospital

    collaborator OTHER
  • Sunnybrook Health Sciences Centre

    collaborator OTHER
  • St. Paul's Hospital, Canada

    collaborator OTHER
  • University of Alberta

    collaborator OTHER
  • Unity Health Toronto

    collaborator OTHER
  • The Ottawa Hospital

    collaborator OTHER
  • Capital Health Nova Scotia

    collaborator UNKNOWN
  • Christopher Chan

    lead OTHER

Principal Investigators

  • Christopher T Chan, MD · University Health Network, Toronto

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-12-31
Completion
2016-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01912001 on ClinicalTrials.gov